C H Ashton|M D Rawlins|S P Tyrer - JoVE Visualize

Showing results (191-200 of 208) with videos related to

Pageof 21

Sort By:

European Journal of Clinical Pharmacology|March 11, 1977

Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertensionP A Routledge, L V Zrinzo, J G Rao, et al.

British Journal of Clinical Pharmacology|January 1, 1979

A comparative study of methyldopa and labetalol in the treatment of hypertensionG L Sanders, D M Davies, G M Gales, et al.

Bipolar Disorders|May 3, 2001

Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorderS M El-Badri, C H Ashton, P B Moore, et al.

Journal of Intellectual Disability Research : JIDR|February 27, 2003

Preliminary evaluation of a scale to assess cognitive function in adults with Down's syndrome: the Prudhoe Cognitive Function TestD W K Kay, S P Tyrer, M L Margallo-Lana, et al.

British Journal of Clinical Pharmacology|December 3, 1999

Attitudinal survey of voluntary reporting of adverse drug reactionsI A Eland, K J Belton, A C van Grootheest, et al.

European Journal of Clinical Pharmacology|January 1, 1984

A comparative study of the effects of aspirin and paracetamol (acetaminophen) on platelet aggregation and bleeding timeR A Seymour, F M Williams, A Oxley, et al.

British Medical Journal (Clinical Research Ed.)|October 10, 1981

Blood concentrations of acetaldehyde during chlorpropamide-alcohol flushA H Barnett, C Gonzalez-Auvert, D A Pyke, et al.

Journal of Intellectual Disability Research : JIDR|May 12, 2007

Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathologyM L Margallo-Lana, P B Moore, D W K Kay, et al.

Neuroreport|June 27, 1994

Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21)R Raghavan, C Khin-Nu, A G Brown, et al.

The Quarterly Journal of Medicine|February 1, 1985

Pharmacokinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance eliminationD N Bateman, P G Blain, K W Woodhouse, et al.

Pageof 21

Showing results (191-200 of 208) with videos related to

Sort By:

Pageof 21

European Journal of Clinical Pharmacology|March 11, 1977

Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertensionP A Routledge, L V Zrinzo, J G Rao, et al.

British Journal of Clinical Pharmacology|January 1, 1979

A comparative study of methyldopa and labetalol in the treatment of hypertensionG L Sanders, D M Davies, G M Gales, et al.

Bipolar Disorders|May 3, 2001

Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorderS M El-Badri, C H Ashton, P B Moore, et al.

Journal of Intellectual Disability Research : JIDR|February 27, 2003

Preliminary evaluation of a scale to assess cognitive function in adults with Down's syndrome: the Prudhoe Cognitive Function TestD W K Kay, S P Tyrer, M L Margallo-Lana, et al.

British Journal of Clinical Pharmacology|December 3, 1999

Attitudinal survey of voluntary reporting of adverse drug reactionsI A Eland, K J Belton, A C van Grootheest, et al.

European Journal of Clinical Pharmacology|January 1, 1984

A comparative study of the effects of aspirin and paracetamol (acetaminophen) on platelet aggregation and bleeding timeR A Seymour, F M Williams, A Oxley, et al.

British Medical Journal (Clinical Research Ed.)|October 10, 1981

Blood concentrations of acetaldehyde during chlorpropamide-alcohol flushA H Barnett, C Gonzalez-Auvert, D A Pyke, et al.

Journal of Intellectual Disability Research : JIDR|May 12, 2007

Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathologyM L Margallo-Lana, P B Moore, D W K Kay, et al.

Neuroreport|June 27, 1994

Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21)R Raghavan, C Khin-Nu, A G Brown, et al.

The Quarterly Journal of Medicine|February 1, 1985

Pharmacokinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance eliminationD N Bateman, P G Blain, K W Woodhouse, et al.

Pageof 21